Medical Milestone Achieved By This Health Company For New Treatment

Abeona Therapeutics Receives Priority Review from FDA for Pioneering Gene Therapy.

In a major medical and scientific milestone, Abeona Therapeutics Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the Biologics License Application (BLA) for pz-cel (prademagene zamikeracel).

Pz-cel is Abeona's investigational autologous, COL7A1 gene-corrected epidermal sheets for the treatm…